Department of Biostatistics and Informatics
M.S., Biostatistics, University of Colorado Denver, Aurora, Colorado; December 2010 (expected)
• Advisors: Samantha MaWhinney and Peter L. Anderson
• Thesis: A Comparison of Two Approaches for Modeling the Population Pharmacokinetics of Atazanavir
in HIV-Negative Adults using NONMEM and SAS
B.A., Mathematics, Chinese Language and Literature (double-major), University of Colorado at Boulder;May 2001
Advanced Chinese, University College, University of Denver, Denver, Colorado; 2005Intensive Chinese Language Program, College of Intensive Chinese Studies, Beijing Language andCulture University, Beijing, China; 2004
Research Assistant, Dr. Samantha MaWhinney, Dept. of Biostatistics and Informatics, and Dr. Peter L. Anderson, Dept. of Pharmaceutical Sciences, University of Colorado Denver, 2009-Present
• pharmacokinetic modeling using NONMEM
Research Assistant, Dr. John Kittelson, Colorado Biostatistics Consortium, University of Colorado Den-ver, 2009-Present
• general statistical support and consultation
Julie Marshall, Rocky Mountain Prevention Research Center, University of
• database creation and data management
• general statistical support and consultation
Assistant Translator, Beijing Commercial Information Consultation Center, Beijing, China, 2005
• translation projects for the 2008 Olympics
Teacher, Adolescent Counseling Exchange Charter School, Denver, CO 2002
Instructor’s Assistant, University of Colorado, Boulder, CO, 2000-2001
Clinical Trials, FDA Requirements, and Good Clinical Practice Workshop, Regional Training Center forProduct Translation, Colorado State University, Aurora, CO. July, 2010
Population Pharmacokinetic and NONMEM Workshop, Department of Pharmaceutical Sciences, Univer-sity of Colorado Denver, Aurora, CO. July, 2009
Building and Managing Databases with Research Electronic Data Capture (REDCap), Colorado Clinical& Translational Sciences Institute, University of Colorado Denver, Aurora, CO. July, 2009
Pharmacokinetic Working Group− Conducted by Dr. Peter L. Anderson, Department of Pharmaceutical Sciences, University of ColoradoDenver. − Monthly seminars to discuss chapters and work problems from Clinical Pharmacokinetics and Pharmaco-dynamics: Concepts and Applications, Rowland and Tozer, 4th edition.
Pharmacokinetic/Pharmacogenomic Interest Group− Organized by The University of Colorado Denver Center for Translational Pharmacokinetics and Phar-macogenomics. − Monthly forum to discuss journal articles and to present current research. − Past article and presentation topics: Clearance Concepts, The PK of Omeprazole and Pantoprazole inChildren, Relating In Vitro Metabolism/Transport Data to the In Vivo Setting, and A NONMEM PopulationApproach to Model the Pharmacogenetics of Atazanavir and Ritonavir in Adult Volunteers.
Title: A NONMEM Population Approach to Model the Pharmacogenetics of Atazanavir and Ritonavir inHIV-Negative Adults− Joint Statistical Meeting (August, 2010), Vancouver, BC, Canada
Title: Overview of Current Thesis Topics: Population Pharmacokinetics and NONMEM− Department of Biostatistics Student Seminar Series (May, 2010), University of Colorado Denver, Aurora,CO
Title: A NONMEM Population Approach to Model the Pharmacogenetics of Atazanavir and Ritonavirin Adult Volunteers− Pharmacokinetic/Pharmacogenomic Interest Group, The University of Colorado Denver Center for Trans-lational Pharmacokinetics and Pharmacogenomics (Feb, 2010), Aurora, CO
Kile DA, MaWhinney S, Rower JE, Anderson PL. A NONMEM Population Pharmacokinetic Approach toModel the Pharmacogenetics of Atazanavir / Ritonavir in Adult Volunteers. To appear in Human Genomics.
Kile DA. A Comparison of Two Approaches for Modeling the Population Pharmacokinetics of Atazanavirand Ritonavir in HIV-Negative Adults using NONMEM and SAS .
• Department of Biostatistics Student Committee founding member, University of Colorado Denver,
• Department of Biostatistics Student Seminar Series Co-Orgainzer, University of Colorado Denver,
• American Statistical Association, Colorado/Wyoming Chapter, 2009-present
• Proficient in computer programming (NONMEM, PDxPop, R, SAS, LATEX, REDCap)
• Proficient in Mandarin Chinese (speaking, reading, writing)
Samantha MaWhinney, Sc.D. ProfessorDepartment of Biostatistics and Informatics Co-Director, Biostatistics MS & PhD programsColorado School of Public HealthUniversity of Colorado Denverphone: (303) 724.4368email: [email protected]
Gary Grunwald, Ph.D. ProfessorDepartment of Biostatistics and Informatics Co-Director, Biostatistics MS & PhD programsColorado School of Public HealthUniversity of Colorado Denverphone: (303) 724.4360email: [email protected]
Peter L. Anderson, Pharm.D. Associate ProfessorDepartment of Pharmaceutical SciencesUniversity of Colorado Denver
phone: (303) 724.6128email: [email protected]
John Kittelson, Ph.D. Associate ProfessorColorado Biostatistics Consortium DirectorDepartment of Biostatistics and InformaticsColorado School of Public HealthUniversity of Colorado Denverphone: (303) 724.4364email: [email protected]
Processrätt Reviderad 2011-10-07 Övningsuppgifterna syftar till att ni ska få möjlighet att träna er i att identifiera de juridiska problem som finns i uppgifterna samt att lösa dessa. En stor del av den juridiska problemlösningen handlar om att kunna argumentera för varför en viss lösning ska väljas. För att träna er i den konsten, inför tentan, är det för er egen del bra
I framtiden kommer pulsvågshastighet och pulsvågsförstärkning (augmen-tation) att bli värdeful a variabler för att prognosticera CVD och att följa en värdefull variabel att följa hos dia-terapin av hypertension, angina, hjärtsvikt, njursvikt och diabetes. Det skri-betiker i syfte att optimera terapin. ver här docent Gunnar Nyberg, Sahlgrenska sjukhuset, Göteborg. Njurinsufficiens